StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.36−0.01 (-0.73%)

Close on Nov 19, 2026Market cap $86.67MP/E –Yield –

Earnings

TuHURA Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 31, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2023
–
EPS, Q3 FY2023
-$1.94
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of TuHURA Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 31, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026before the open–––Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 15, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Apr 1, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025after the close–––Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close–––Release
Q4 FY2023ended Jun 30, 2023Sep 18, 2023after the close–––Release
Q3 FY2023ended Mar 31, 2023May 11, 2023before the open––-$1.94Release
Q2 FY2023ended Dec 31, 2022Feb 14, 2023after the close––-$2.10Release
Q1 FY2023ended Sep 30, 2022Nov 9, 2022after the close––-$0.07Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

TuHURA Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When TuHURA Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases TuHURA Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. News
  6. Update
  7. News
  8. Results
  9. News
  10. News
  11. Results
  12. News
  13. News
  14. News
  15. Results

See a number that looks wrong?